Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities.
about
Vaccine applications of flow cytometryEffective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression levelT-Cell tropism of simian varicella virus during primary infectionHepatitis C virus immune escape via exploitation of a hole in the T cell repertoireA Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor.Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cellsHuman naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells.Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus diseaseReprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection.High throughput T epitope mapping and vaccine developmentExpanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System.Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipientsIntegrated Raman and angular scattering microscopy reveals chemical and morphological differences between activated and nonactivated CD8+ T lymphocytes.Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccinationDiverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells.Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cellsPitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909.In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cellsPrimed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapyDetection and preliminary characterization of CD8+T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphoma.Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplantPathogenesis of varicelloviruses in primatesGeneration of tumor antigen-specific T cell lines from pediatric patients with acute lymphoblastic leukemia--implications for immunotherapy.Combining next-generation sequencing and immune assays: a novel method for identification of antigen-specific T cellsNatural killer T cells in advanced melanoma patients treated with tremelimumabAspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinomaSynthetic consensus HIV-1 DNA induces potent cellular immune responses and synthesis of granzyme B, perforin in HIV infected individualsCodon optimization of the human papillomavirus E7 oncogene induces a CD8+ T cell response to a cryptic epitope not harbored by wild-type E7Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset.Current advances in T-cell-based cancer immunotherapyComplete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells.Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb.Deconvolving heterogeneity in the CD8+ T-cell response to HIV.Analysis of the functional WT1-specific T-cell repertoire in healthy donors reveals a discrepancy between CD4(+) and CD8(+) memory formation.Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients.Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6Selection of single chain antibody fragments binding to the extracellular domain of 4-1BB receptor by phage display technology.Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial
P2860
Q27004341-361B0D67-9469-4944-A059-B7C0B60180C2Q27300701-88A11F66-2C66-4A6E-B7D4-99804F09FD60Q27334810-3D28F4AE-FCFB-4919-8052-9AE05FFF457BQ27489598-9377C970-3BF2-43CD-818A-D49AD839D784Q30385378-30FF6F83-BCE1-47C5-BDB4-E0D76F3359CBQ30573747-289AA190-7303-47CD-80C0-1013A0E3B862Q30591778-3E6710D8-1414-405F-9ED8-793EDCEE6FADQ33476079-AB051D2B-FBAB-473B-9808-E5FDB3C0579FQ33523611-3BA46F90-5298-4CAC-B291-4DADEFD2ADC6Q33581986-BE1FCB11-3DAE-44D5-9B76-D706E2898B8BQ33628719-EAD2A3B7-82B1-4AE3-8236-1E2423A394F5Q33770508-EC531A6F-D79F-4E30-8B2B-52DF1519211DQ33932079-7ECFECDB-85E3-4A6F-95BA-4BEC14756941Q33993307-6B9D6269-73DD-40F2-A3CF-8A93B000E5C6Q34068404-4DF62EC2-DA8D-4A26-B8A7-5CC8F61A2A1BQ34262249-91358F85-1777-485D-9FBC-50E5B57A3CE0Q34279672-FE4405FD-6840-47C5-9D01-C1493CC5FA31Q34307987-F4B078AD-2508-4491-B9FC-ED95E013EDEEQ34508125-F92BCC3B-B948-4341-B8AC-48EDCE93E227Q34560957-37AF99DC-9B73-48D2-B734-041A69039DE2Q34594769-4AEBB1B3-B55C-4AD1-A72B-E71421819F00Q34616701-74B2287B-6EDD-44CC-8BEF-9EB07EDBF7DDQ34635978-56139266-EEAB-4347-A043-6A67162A8DDFQ34714480-41D261B6-7398-40B2-AEA9-4555FFED2820Q34803707-91AEC614-AC5F-4FC5-B2C0-3BD47FA30D16Q34999059-C330B998-F09D-4A18-9B86-D5228F4B4E4FQ35027661-FD38E6B5-CE75-426B-96C3-CD2DCF5873D1Q35091441-62F26681-3F8E-46F1-92AD-312635AF8CB7Q35153129-3DE08558-B984-4220-AA51-B3DA67249057Q35208290-72F98AD8-42F6-4279-8844-280644EB2593Q35214233-2EF65556-DD1B-473F-817B-5F40559E5F53Q35215158-F594B1F2-DABF-4732-9FB6-B22134A9E48EQ35563824-811AD304-FF13-49E9-B2C7-97FA12178B5EQ35764479-88101A3A-4C1F-4D0E-9D72-97F0EDDB852BQ35793089-3EC2C662-8BD1-41B7-ACBE-F8B26F1EBB07Q35889240-61C081D7-FFBF-4F66-BF1E-6E42B5E7EC41Q35939427-6ED68B72-3680-4362-8B3B-645EEE8D14E7Q36154471-D07D0B33-FD20-4A89-AC55-75922EFDAA6FQ36324254-64B0A866-ACEE-4943-8D52-FFEBFB33442AQ36506169-8F187106-98C1-40E1-A88B-DE3935D3228C
P2860
Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Activation-induced expression ...... edge of epitope specificities.
@ast
Activation-induced expression ...... edge of epitope specificities.
@en
type
label
Activation-induced expression ...... edge of epitope specificities.
@ast
Activation-induced expression ...... edge of epitope specificities.
@en
prefLabel
Activation-induced expression ...... edge of epitope specificities.
@ast
Activation-induced expression ...... edge of epitope specificities.
@en
P2093
P2860
P1433
P1476
Activation-induced expression ...... edge of epitope specificities.
@en
P2093
Hieu Nguyen
Jürgen Kuball
Marie Bleakley
Matthias Wolfl
Philip D Greenberg
Thomas J Manley
William Y Ho
P2860
P304
P356
10.1182/BLOOD-2006-11-056168
P407
P577
2007-03-19T00:00:00Z